Literature DB >> 25232499

Renal complications of beta-thalassemia major in children.

Ashraf Bakr1, Youssef Al-Tonbary2, Ghada Osman3, Rasha El-Ashry2.   

Abstract

The success that has been made in the care of patients with thalassemia has led to the emergence of unrecognized complications including several renal abnormalities. Chronic anemia and iron overload as well as the use of iron chelator are believed to lie behind these abnormalities. Many investigators document the presence of tubular dysfunction and abnormalities in glomerular filtration rate in these patients. In this review we will discuss the updates in the diagnosis, pathogenesis and prevention of renal complications of thalassemia.

Entities:  

Keywords:  Children; renal complications; thalassemia

Year:  2014        PMID： 25232499      PMCID： PMC4165117     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN： 2160-1992


  39 in total

1.  Function of the kidney in adult patients with Cooley's disease. A preliminary report.

Authors:  F Mastrangelo; T Lopez; S Rizzelli; G Manisco; C Corlianò; L Alfonso
Journal:  Nephron       Date:  1975       Impact factor: 2.847

2.  Renal function in pediatric patients with beta-thalassemia major.

Authors:  B Aldudak; A Karabay Bayazit; A Noyan; A Ozel; A Anarat; I Sasmaz; Y Kilinç; E Gali; R Anarat; N Dikmen
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

3.  Acute renal failure following deferoxamine overdose.

Authors:  Salvatore Li Volti; Carmela Maccarone; Giovanni Li Volti; Maria A Romeo
Journal:  Pediatr Nephrol       Date:  2003-08-14       Impact factor: 3.714

4.  Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.

Authors:  Manuela Balocco; Paola Carrara; Valeria Pinto; Gian Luca Forni
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

5.  Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis.

Authors:  B H Landing; H C Gonick; R L Nadorra; C B Hyman; T R Wells; G Villarreal-Engelhardt; J Mersch; C L Agness
Journal:  Pediatr Pathol       Date:  1989

6.  Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Authors:  Caterina Borgna-Pignatti; Maria Domenica Cappellini; Piero De Stefano; Giovanni Carlo Del Vecchio; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Maria Antonietta Romeo; Huaqing Zhao; Avital Cnaan
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

7.  Renal enlargement in thalassemia major.

Authors:  H Grossman; M R Dische; P H Winchester; V Canale
Journal:  Radiology       Date:  1971-09       Impact factor: 11.105

8.  Mechanisms of renal disease in β-thalassemia.

Authors:  Khaled M Musallam; Ali T Taher
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

9.  Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

Authors:  Asma Kassab-Chekir; Sandrine Laradi; Selima Ferchichi; Amel Haj Khelil; Moncef Feki; Fathi Amri; Habib Selmi; Mohamed Bejaoui; Abdelhédi Miled
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

10.  Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload.

Authors:  Yesim Aydinok; Sule Unal; Yesim Oymak; Canan Vergin; Zeynep D Türker; Dilek Yildiz; Akif Yesilipek
Journal:  Eur J Haematol       Date:  2012-03-07       Impact factor: 2.997
View more
  5 in total

1.  Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients.

Authors:  Mozhgan Hashemieh; Mitra Radfar; Azita Azarkeivan; Seyed Mohammad Taghi Hosseini Tabatabaei; Sedigheh Nikbakht; Mehdi Yaseri; Kourosh Sheibani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

2.  Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major.

Authors:  Asmaa A Mahmoud; Doaa M Elian; Nahla Ms Abd El Hady; Heba M Abdallah; Shimaa Abdelsattar; Fatma O Khalil; Sameh A Abd El Naby
Journal:  Children (Basel)       Date:  2021-02-03

3.  Renal function in β-thalassemia major patients treated with two different iron-chelation regimes.

Authors:  Osama Tanous; Yossi Azulay; Raphael Halevy; Tal Dujovny; Neta Swartz; Raul Colodner; Ariel Koren; Carina Levin
Journal:  BMC Nephrol       Date:  2021-12-20       Impact factor: 2.388

4.  Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia.

Authors:  Mohammad G Shaalan; Meaad K Hassan; Hamid J Al-Shanoof; Lamia M Al Naama
Journal:  Cureus       Date:  2022-09-15

5.  Cardiorenal syndrome in thalassemia patients.

Authors:  Sorasak Makmettakul; Adisak Tantiworawit; Arintaya Phrommintikul; Pokpong Piriyakhuntorn; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada; Kanda Fanhchaksai; Pimlak Charoenkwan; Suree Lekawanvijit
Journal:  BMC Nephrol       Date:  2020-08-03       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.